Guideline: USPSTF recommends preexposure prophylaxis with antiretroviral therapy for persons at high risk for HIV
Singh, M.
Annals of Internal Medicine 171(8): Jc38
2019
ISSN/ISBN: 1539-3704 PMID: 31610551 DOI: 10.7326/acpj201910150-038Document Number: 639851
Document emailed within 0-6 h
Related Documents
Schneider, J.; Kumar, R.; Dandona, R.; Kumar, P.; Kumar, A.; Lakshmi, V.; Laumann, E.; Mayer, K.; Dandona, L. 2012: Social network and risk-taking behavior most associated with rapid HIV testing, circumcision, and preexposure prophylaxis acceptability among high-risk Indian men Aids Patient Care and Stds 26(10): 631-640Murnane, P.M.; Celum, C.; Mugo, N.; Campbell, J.D.; Donnell, D.; Bukusi, E.; Mujugira, A.; Tappero, J.; Kahle, E.M.; Thomas, K.K.; Baeten, J.M.; Baeten, J.M.; Donnell, D.; Coombs, R.W.; Frenkel, L.; Hendrix, C.W.; Lingappa, J.; McElrath, M..Juliana. 2013: Efficacy of preexposure prophylaxis for HIV-1 prevention among high-risk heterosexuals: subgroup analyses from a randomized trial Aids 27(13): 2155-2160
Thigpen, M.C.; Kebaabetswe, P.M.; Paxton, L.A.; Smith, D.K.; Rose, C.E.; Segolodi, T.M.; Henderson, F.L.; Pathak, S.R.; Soud, F.A.; Chillag, K.L.; Mutanhaurwa, R.; Chirwa, L.Ian.; Kasonde, M.; Abebe, D.; Buliva, E.; Gvetadze, R.J.; Johnson, S.; Sukalac, T.; Thomas, V.T.; Hart, C.; Johnson, J.A.; Malotte, C.Kevin.; Hendrix, C.W.; Brooks, J.T.; Toomey, K.; Davis, M.; Shepherd, J.; Sukalac, T.; Abebe, D.; Baakile, K.; Balopi, W.; Bolobilwe, O.; Buliva, E.; Byrd, D.; Casillas, P.; Chanda, J.; Chilume, O.; Chirwa, I.; Cobb, D.; Dikgole, K.; Dikgope, S.; Fonjun 2012: Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana New England Journal of Medicine 367(5): 423-434
Diouf, A.; Youbong, T.J.; Maynart, M.; Ndoye, M.; Diéye, F.L.; Ndiaye, N.A.; Koita-Fall, M.B.; Ndiaye, B.; Seydi, M. 2017: Non-antiretroviral drugs uses among HIV-infected persons receiving antiretroviral therapy in Senegal: Costs and factors associated with prescription Revue d'Epidemiologie et de Sante Publique 65(4): 295-300
Kaye, D.K.; Kakaire, O.; Osinde, M.O.; Lule, J.C.; Kakande, N. 2013: The impact of highly active antiretroviral therapy on high-risk behaviour of HIV-infected patients in sub-Saharan Africa Journal of Infection in Developing Countries 7(6): 436-447
Graham, S.M.; Mugo, P.; Gichuru, E.; Thiong'o, A.; Macharia, M.; Okuku, H.S.; van der Elst, E.; Price, M.A.; Muraguri, N.; Sanders, E.J. 2013: Adherence to antiretroviral therapy and clinical outcomes among young adults reporting high-risk sexual behavior, including men who have sex with men, in coastal Kenya Aids and Behavior 17(4): 1255-1265
Qian, X.; Cao, X.; Zhao, Y.; Jin, Y.; Willa, D.; Luo, W.; Wang, C.; Rou, K.; Zhang, B.; Duan, S.; Tang, R.; Wu, Z. 2015: Impact of antiretroviral therapy on drug-using and high risk sexual behaviors among HIV-positive methadone maintenance treatment clients: a qualitative study Zhonghua Liu Xing Bing Xue Za Zhi 36(1): 49-51
Ji, Y. 2020: A comparison of fact sheets that promote preexposure prophylaxis (Pr EP) use among men who have sex with men Communication Research Reports 37(3): 65-73
Sineath, R.Craig.; Finneran, C.; Sullivan, P.; Sanchez, T.; Smith, D.K.; Griensven, F.van.; Wimonsate, W.; Stephenson, R. 2013: Knowledge of and interest in using preexposure prophylaxis for HIV prevention among men who have sex with men in Thailand Journal of the International Association of Providers of Aids Care 12(4): 227-231
Hughes, G.D.; Puoane, T.R.; Clark, B.L.; Wondwossen, T.L.; Johnson, Q.; Folk, W. 2012: Prevalence and predictors of traditional medicine utilization among persons living with AIDS (PLWA) on antiretroviral (ARV) and prophylaxis treatment in both rural and urban areas in South Africa African Journal of Traditional Complementary and Alternative Medicines: Ajtcam 9(4): 470-484
Delany-Moretlwe, S.éa.; Mullick, S.; Eakle, R.; Rees, H. 2016: Planning for HIV preexposure prophylaxis introduction: lessons learned from contraception Current Opinion in HIV and Aids 11(1): 87-93
Marrazzo, J.M.; Ramjee, G.; Richardson, B.A.; Gomez, K.; Mgodi, N.; Nair, G.; Palanee, T.; Nakabiito, C.; van der Straten, A.; Noguchi, L.; Hendrix, C.W.; Dai, J.Y.; Ganesh, S.; Mkhize, B.; Taljaard, M.; Parikh, U.M.; Piper, J.; Mâsse, Bît.; Grossman, C.; Rooney, J.; Schwartz, J.L.; Watts, H.; Marzinke, M.A.; Hillier, S.L.; McGowan, I.M.; Chirenje, Z.Mike.; Chirenje, Z.Mike.; Marrazzo, J.; Bragg, V.; Gomez, K.; Horn, S.; Levy, L.; Mayo, A.; Moore, A.T.; Richards, K.; Schwartz, K.; White, R.; Torjesen, K.; Borgerding, J.; Gandham, S 2015: Tenofovir-based preexposure prophylaxis for HIV infection among African women New England Journal of Medicine 372(6): 509-518
Douglas, S.D.; Rudy, B.; Muenz, L.; Moscicki, A.B.; Wilson, C.M.; Holland, C.; Crowley-Nowick, P.; Vermund, S.H. 1999: Peripheral blood mononuclear cell markers in antiretroviral therapy-naive HIV-infected and high risk seronegative adolescents. Adolescent Medicine HIV/AIDS Research Network Aids 13(13): 1629-1635
Psaros, C.; Haberer, J.E.; Katabira, E.; Ronald, A.; Tumwesigye, E.; Campbell, J.D.; Wangisi, J.; Mugwanya, K.; Kintu, A.; Enyakoit, M.; Thomas, K.K.; Donnell, D.; Krows, M.; Kidoguchi, L.; Ware, N.; Baeten, J.M.; Celum, C.; Bangsberg, D.R.; Safren, S.A. 2014: An intervention to support HIV preexposure prophylaxis adherence in HIV-serodiscordant couples in Uganda Journal of Acquired Immune Deficiency Syndromes 66(5): 522-529
Heffron, R.; Mugo, N.; Were, E.; Kiarie, J.; Bukusi, E.A.; Mujugira, A.; Frenkel, L.M.; Donnell, D.; Ronald, A.; Celum, C.; Baeten, J.M.; Celum, C.; Baeten, J.M.; Donnell, D.; Coombs, R.W.; Frenkel, L.M.; Hendrix, C.W.; Lingappa, J.; McElrath, M..Juliana.; Fife, K.; Were, E.; Tumwesigye, E.; Katabira, E.; Katabira, E.; Bukusi, E.; Cohen, C.; Wangisi, J.; Campbell, J.; Tappero, J.; Kiarie, J.; Farquhar, C.; John-Stewart, G.; Mugo, N.Rwamba.; Campbell, J.; Tappero, J.; Wangisi, J. 2014: Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception Aids 28(18): 2771-2776
Peinado, J.; Lama, J.R.; Galea, J.T.; Segura, P.; Casapia, M.; Ortiz, A.; Montano, S.M.; Kochel, T.; Sánchez, J. 2013: Acceptability of oral versus rectal HIV preexposure prophylaxis among men who have sex with men and transgender women in Peru Journal of the International Association of Providers of Aids Care 12(4): 278-283
Cornella, C.; Torazza, M.C.; Strippoli, G.F.M.; Segoloni, G. 2007: Antiviral prophylaxis and pre-emptive therapy for the prevention of Cytomegalovirus infection in renal transplant recipients: guideline from the Italian Society of Nephrology Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 24 Suppl. 37: S165-S178
Dai, J.Y.; Gilbert, P.B.; Hughes, J.P.; Brown, E.R. 2013: Estimating the efficacy of preexposure prophylaxis for HIV prevention among participants with a threshold level of drug concentration American Journal of Epidemiology 177(3): 256-263
Donato, F.; Monarca, S.; Spiazzi, R.; Feretti, D.; Soldo, M.; Boschi, G.; Bonetti, F.; Nardi, G. 1990: Knowledge about AIDS and attitudes in comparisons of persons at high risk of contracting the disease: a survey of high school students of Brescia Annali di Igiene: Medicina Preventiva e di Comunita 2(1-2): 47-55
Aragonés, C.; Sánchez, L.; Campos, J.R.; Pérez, J. 2011: Antiretroviral therapy adherence in persons with HIV/AIDS in Cuba Medicc Review 13(2): 17-23